9 January 20232 minute read

The current state of life sciences transactions

Hosted by DLA Piper’s Life Sciences Sector

January 9, 2023 | 11:30 am – 2:00 pm PT

The pharmaceutical industry is facing another year of market and geopolitical upheaval. We anticipate life sciences investments, mergers and acquisitions, and strategic partnering activities to continue, but how will these transactions be affected by the evolving, uncertain environment?

Please join us for an informative panel discussion with leading financing sources and DLA Piper partners during the J.P. Morgan Healthcare Conference. Our panelists will provide their insights into where they see life sciences investments headed in 2023.

Event is by invitation only.

For more information, contact Shannon Tomassi.

Agenda

Registration: 11:30 am – 12:00 pm PT

Lunch and program: 12:00 – 2:00 pm PT

Speakers

Andrew Gilbert

Global Co-Chair, Life Sciences Sector, DLA Piper
Bio
regosa

Emilio Ragosa

Managing Partner, Short Hills and Atlantic City Offices, DLA Piper
Bio

Kate Walsh

Market Manager, Biopharma, Tools & Diagnostics, Silicon Valley Bank
Bio

Bill Taranto

President, Merck Global Health Innovation Fund LLC
Bio

Lucian Iancovici

Business Unit Partner, TPG Growth
Bio

Rajeev Dadoo, PhD

Managing Partner, SR One
Bio

Andrew Meyerson

Managing Director, Locust Walk LLC
Bio
Print